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Edited by Gianni CesareniAbstract RPE65, a membrane-associated protein in the retinal
pigment epithelium, is the isomerohydrolase essential for regen-
erating 11-cis retinal, the chromophore for visual pigments.
RPE65 mutations are associated with inherited retinal dystro-
phies. Here we report that single point mutations of RPE65,
Y144D and P363T, identiﬁed in patients with Leber’s congenital
amaurosis (LCA), signiﬁcantly decreased the stability of
RPE65. Moreover, these mutations altered subcellular localiza-
tion of RPE65 and abolished its isomerohydrolase activity.
These observations suggest that the decreased protein stability
and altered subcellular localization of RPE65 may represent a
mechanism for these mutations to lead to vision loss in LCA
patients.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The phototransduction pathway initiates after the light-in-
duced isomerization of 11-cis retinal, the chromophore for
visual pigments of both rod and cone photoreceptors, to its
all-trans isomer [1,2]. Recycling of 11-cis retinal through
the retinoid visual cycle is essential for the regeneration of
visual pigments and for normal vision [2–5]. A key step in
the visual cycle is the conversion of all-trans retinyl ester to
11-cis retinol by a single enzyme, isomerohydrolase, in the
retinal pigment epithelium (RPE) [3,6]. Recent studies have
indicated that RPE65 is the isomerohydrolase which pro-
duces 11-cis retinol from all-trans retinyl ester [7–9]. Its isom-
erohydrolase activity requires lecithin retinol acyltransferase
(LRAT) in the same membrane as a functional partner to
provide all-trans retinyl ester, the hydrophobic substrate of
RPE65 [10].Abbreviations: CHX, cycloheximide; LCA, Leber’s congenital amau-
rosis; LRAT, lecithin retinol acyltransferase; MOI, multiplicity of in-
fection; RPE, retinal pigment epithelium; ER, endoplasmic reticulum
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doi:10.1016/j.febslet.2006.06.078RPE65 is an abundant membrane-associated protein in the
retinal pigment epithelium (RPE), associated with endoplasmic
reticulum (ER) [11]. A number of mutations in the RPE65
gene which cause truncation of the protein or amino acid sub-
stitutions have been shown to associate with inherited retinal
dystrophies in patients, such as retinitis pigmentosa (RP), Le-
ber’s congenital amaurosis (LCA) and early-onset severe reti-
nal dystrophies [12–17]. Recent studies showed that some of
the RPE65 mutations in patients impair the isomerohydrolase
activity of RPE65 [7,18]. However, the molecular mechanisms
for these mutations, especially the mis-sense mutations, to im-
pair its isomerohydrolase activity and consequent retinal
degeneration have not been elucidated.
In the present studies, we studied the impacts of two point
mutations of RPE65, Y144D and P363T, identiﬁed in patients
with LCA, on the stability, subcellular localization and enzy-
matic activity of RPE65.2. Methods
2.1. Site-directed mutagenesis, expression and isomerohydrolase activity
assay
Point mutations Y144D and P363T were generated using the Quick-
Change site-directed mutagenesis kit (Stratagene, La Jolla, CA) using
the wild-type (wt) human RPE65 cDNA as the template and conﬁrmed
by DNA sequencing from both strands [18]. Generation of recombi-
nant adenoviruses, measurements of the expression and isomerohydro-
lase activities were as described [8].
2.2. Real-time RT-PCR
The cells were infected with adenoviruses expressing wt and mutant
RPE65 for 18 h; then the cells were harvested and washed with
RNase-free PBS twice on ice. The RNA was isolated using RNAeasy
(Qiagen, Valencia, CA) according to manufacturer’s protocol. RNA
was treated with RNase-free DNase I (Invitrogen, Carsbad, CA)
for 15 min to remove possible contamination from the virus or geno-
mic DNA. The treated RNA was used for reverse transcription as de-
scribed previously [18]. The generated cDNA was used as the
template for real-time PCR using a pair of primers speciﬁc for human
RPE65 cDNA. The 18s rRNA was used as a reference for normali-
zation of the PCR products from the RPE65 mRNA. To exclude any
possible ampliﬁcation from trace viral DNA, a negative control
which omits reverse transcriptase in the RT reaction was used for
each RT-PCR.
2.3. Sub-cellular fractionation
The infected QBI-293A cells were lysed. Total cell lysates were
separated into cytosolic, membrane, nuclear, and cytoskeletal frac-
tions with FractPrepe (BioVision, Mountain View, CA), followingblished by Elsevier B.V. All rights reserved.
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each fraction was applied to 8% gel for SDS–PAGE and Western blot
analysis using an antibody speciﬁc for RPE65 [10,19].
2.4. Immunocytochemistry
The QBI-293A cells expressing wtRPE65 and its mutants were cul-
tured on coverslip and then ﬁxed with 4% paraformaldehyde. After
blocking, the cells were incubated with a mouse anti-disulﬁde isomer-
ase (an ER marker) antibody (Invitrogene, La Jolla, CA) and a rabbit
anti-RPE65 antibody for 2 h. After three washes, the slides were incu-
bated with a Texas Red-conjugated goat anti-rabbit antibody and an
FITC-conjugated goat anti-mouse antibody (Jackson ImmunoRe-
search Lab. Inc., West Grove, PA) at a dilution of 1:150 for 30 min.
Then, the slides were rinsed, counter-stained with 4 0,6-diamidino-2-
phenylindole (DAPI) and mounted in Vectashielde mounting media.
The slides were viewed on a LSM 510 laser scanning confocal micro-
scope (Carl Zeiss Meditec, Inc., Jena, Germany).Fig. 1. Decreased protein levels but not the mRNA levels of Y144D
and P363T. (A) Eighteen hours after the viral infection, 50 lg of total
proteins from cells infected with the same titer (MOI 40) of Ad-
wtRPE65, Ad-Y144D and Ad-P363T were blotted with the anti-
RPE65 antibody. (B) RPE65 protein levels were semi-quantiﬁed by
densitometry, normalized by b-actin levels and expressed as % of
wtRPE65 (mean ± S.D., n = 3). (C) mRNA levels of wtRPE65, Y144D
and P363T were quantiﬁed by real-time RT-PCR and expressed as %
of that of wtRPE65 (mean ± S.D., n = 3).3. Results
3.1. Decreased protein levels of RPE65 mutants Y144D and
P363T
Western blot analysis using the same amount of total protein
from 293A-LRAT cells infected with the same titer (MOI 40)
of Ad-wtRPE65, Ad-Y144D and Ad-P363T showed that both
of the mutations signiﬁcantly decreased RPE65 protein levels,
when compared to that of wtRPE65 (Fig. 1A and B). Under
the same culture condition, however, mRNA levels of these
mutants had no signiﬁcant diﬀerence from that of wtRPE65,
as shown by quantitative real-time RT-PCR [18] (Fig. 1C),
suggesting that the lower protein levels of the mutants cannot
be ascribed to the decreased expression of RPE65. The RT-
PCR without reverse transcriptase (negative control) did not
produce any detectable PCR product, indicating that the
PCR product of RPE65 was not ampliﬁed from virus DNA
contamination (data not shown).
3.2. Mutations Y144D and P363T both abolish the enzymatic
activity of RPE65
The enzymatic activities of mutants Y144D and P363T were
compared with that of wtRPE65 expressed in 293A-LRAT
cells, a stable cell line expressing LRAT, by the in vitro isom-
erohydrolase activity assay using all-trans [3H] retinol as the
substrate as described previously [8]. To exclude possible im-
pacts of the decreased levels of the mutant proteins on their
enzymatic activities, the mutants were over-expressed using a
higher titer of the Ad-Y144D and Ad-P363T (MOI 400). As
showed by Western blot analysis using the same amount of to-
tal cell lysate, protein levels of both the mutants, when ex-
pressed with MOI 400, were comparable to that of wtRPE65
expressed at MOI 20 (Fig. 2A). At the comparable protein lev-
els, however, mutants Y144D and P363T did not generate any
detectable 11-cis [3H] retinol in 293A-LRAT cells although all-
trans retinyl ester was produced by LRAT co-expressed in the
cells (Fig. 2C and D). At a similar expression level, wtRPE65
(expressed with MOI 20) generated signiﬁcant amount of 11-
cis [3H] retinol (Fig. 2B), suggesting that the impaired isomero-
hydrolase activities in the mutants are not ascribed to their de-
creased protein levels (Fig. 2).
3.3. Mutations Y144D and P363T decreased the protein stability
of RPE65
In order to deﬁne the cause for the decreased RPE65 protein
levels by the Y144D and P363 mutations, we have comparedprotein stabilities of these two mutants with wtRPE65 as de-
scribed previously [18]. QBI-293A cells were infected sepa-
rately with Ad-wtRPE65, Ad-Y144D and Ad-P363T at MOI
10. The protein expression was allowed for 18 h and then
stopped by addition of 25 lg/ml of cycloheximide (CHX) to
the culture medium. The cells were harvested at 0, 2, 6 and
10 h after the addition of CHX, and the protein levels of the
wtRPE65 and its mutants were measured by Western blot
analysis and semi-quantiﬁed using densitometry. WtRPE65
showed a high stability, with a half-life more than 10 h
(Fig. 3). Under the same conditions, the Y144D and P363T
mutants exhibited signiﬁcantly accelerated degradations, with
apparent half-lives less than 4 and 2 h, respectively (Fig. 3),
suggesting that these single point mutations destabilize the
RPE65 protein.
3.4. Mutations Y144D and P363T alter subcellular localization
of RPE65
To compare the sub-cellular localization of the RPE65 mu-
tants with wtRPE65, we have performed both immunocyto-
chemistry and cell lysate fractionation. QBI-293A cells
expressing the wtRPE65 and the two mutants were homoge-
nized and fractionated using the FractionPREPe kit. RPE65
abundance in the cytosolic,membrane, nuclear, and cytoskeletal
Fig. 2. Lack of isomerohydrolase activity in RPE65 mutants Y144D and P363T. The 293A-LRAT cells were infected with Ad-wtRPE65 (MOI 20),
Ad-Y144D (MOI 400) and Ad-P363T (MOI 400) to achieve the mutant protein levels comparable to that of wtRPE65. (A) Twenty-two hours after
the infection, 50 lg of total proteins were blotted with the antibody for RPE65. (B–D) Two hundred and ﬁfty micrograms of total proteins from each
sample were used for in vitro isomerohydrolase activity assay, with all-trans [3H] retinol as the substrate, and the generated retinoids analyzed by
HPLC. (B) Cells infected with Ad-wtRPE65. (C) and (D) Cells infected with Ad-Y144D and Ad-P363T, respectively. Peak 1, retinyl esters; 2, 11-cis
retinol.
Fig. 3. Decreased protein stability of mutants Y144D and P363T. (A) QBI-293A cells were separately infected with Ad-wtRPE65, Ad-Y144D and
Ad-P363T (MOI 10). The protein synthesis was stopped by the addition of CHX 18 h after the virus infection. Cells were harvested at 0, 2, 6 and 10 h
following the addition of CHX. RPE65 levels were measured by Western blot analysis with the anti-RPE65 antibody, followed by stripping and
reblotting with an anti-b-actin antibody. (B) RPE65 protein levels were semi-quantiﬁed by densitometry, normalized by b-actin levels and expressed
as % of that before the addition of CHX (mean ± S.D., n = 4).
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tern blot analysis. Unlike wtRPE65 which was present at high
levels in the membrane fraction and at relatively low levels in
the cytosolic fraction, mutants Y144D and P363T showedincreased levels in the cytosolic fraction while decreased levels
in themembrane fraction (Fig. 4A). Both of themutant proteins
were also detected in the cytoskeletal/inclusion body fraction
(Fig. 4A).
Fig. 4. Subcellular localization and fractionation of wtRPE65 and its mutants. (A) Eighteen hours after the infection with Ad-wtRPE65, AdY144D
and Ad-P363T, QBI-293A cells were homogenized and fractionated. Equal amount of protein (10 lg) from the cytosolic, membrane, nuclear and
cytoskeletal (including inclusion body) fractions were blotted with the anti-RPE65 antibody and with antibodies for GSK-3b (cytosol marker), pan-
cadherin (membrane marker), TATA-binding protein (TBP, nucleus marker) and vimentin (cytoskeletal marker). (B–D) The cells infected with Ad-
wtRPE65 (B), Ad-Y144D (C) and Ad-P363T (D) were double-stained with the anti-RPE65 antibody (red) and an antibody speciﬁc for an ER marker
(green). The nucleus was counter-stained with DAPI (blue).
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with ER, the QBI-293A cells expressing wtRPE65, Y144D and
P363T were double stained with an antibody speciﬁc for an ER
marker and the anti-RPE65 antibody. The wtRPE65 signal
was detected in both the ER and plasma membrane
(Fig. 4B), while the Y144D and P363T mutants were detected
mainly in the plasma membrane, but not co-localized with the
ER marker (Fig. 4C and D), demonstrating altered subcellular
distributions of the mutants.4. Discussion
RPE65 is a membrane-associated protein predominantly ex-
pressed in the RPE [11]. Homozygous RPE65 gene knockout
(Rpe65/) mice are deﬁcient in isomerohydrolase activity
and lack 11-cis retinoids, suggesting an interrupted visual cycle
[20]. Furthermore, we and others have recently reported that
RPE65 is the isomerohydrolase converting all-trans retinyl es-
ter to 11-cis retinol, a key step in the visual cycle [8,9].
Although multiple mutations in the RPE65 gene have been
identiﬁed to associate with inherited retinal dystrophies such
as RP, LCA and early-onset severe retinal dystrophies, the im-
pacts of these point mutations on the structure and function of
RPE65 have not been well investigated [12–15]. The present
study reports for the ﬁrst time that two point mutations of
RPE65, Y144D and P363T, identiﬁed in patients with LCA,
both signiﬁcantly decrease RPE65 protein stability and altered
its subcellular localization. These changes may be responsible
for the abolished isomerohydrolase activity of the mutants.RPE65 is a relatively stable protein with a half-life longer
than 10 h, which may be responsible for its abundance in the
RPE. In contrast, the point mutations Y144D and P363T sig-
niﬁcantly shortened the half-lives of RPE65 protein to less
than 4 and 2 h. In contrast, the mRNA levels of these two mu-
tants are similar to that of wtRPE65, suggesting that their
transcription rates are not altered by the mutations. This result
suggests that the accelerated RPE65 protein degradation rates,
possibly due to disturbed protein folding introduced by the
mutations, are responsible for the lower protein levels of the
mutant proteins.
In vitro isomerohydrolase activity assay showed that
wtRPE65 has a robust isomerohydrolase activity when co-ex-
pressed with LRAT. In contrast, mutants Y144D and P363T
lack any detectable enzymatic activity. The abolished enzy-
matic activity cannot be ascribed to the lower protein levels
of the mutants, as even at the levels comparable to that
wtRPE65, which were achieved by over-expression of these
mutants using high titers of the viruses, these RPE65 mutants
still lack any isomerohydrolase activity. Therefore, it is likely
that possible structure distortions introduced by the point
mutations are responsible for the loss of the enzymatic activity.
Immunocytochemistry using double labeling showed that
wtRPE65 is predominantly associated with the ER membrane,
consistent with previous studies [21]. Unlike wtRPE65, both of
the mutants are not localized in ER. Our recent studies sug-
gested that co-localization of RPE65 with LRAT in the same
membrane is essential for its isomerohydrolase activity [8].
The altered subcellular localization of the mutant proteins,
may contribute to their decreased stabilities and abolished
4204 Y. Chen et al. / FEBS Letters 580 (2006) 4200–4204enzymatic activities. Although the structural changes of
RPE65 resulting from these two mutations remain to be inves-
tigated, the present study demonstrates that instability and
mis-localization of RPE65 introduced by mutations Y144D
and P363T may be responsible for the retinal degeneration in
LCA patients. As there is no clinically satisfactory treatment
for LCA and its pathogenesis is not completely understood,
LCA remains a signiﬁcant cause of inherited blindness. The
present study has provided clues for further investigation of
the pathogenesis of LCA and may contribute to the develop-
ment of new therapies.
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